Activation of SphK2 contributes to adipocyte-induced EOC cell proliferation

Epithelial ovarian cancer (EOC) is the leading cause of deaths due to cancer in women. Adipocytes have been suggested to play a key role in the stimulation of EOC growth. However, the mechanisms underlying the adipocyte-induced EOC proliferation remain undefined. Here, we provide the first evidence...

Full description

Bibliographic Details
Main Authors: Dai Lan, Wang Chen, Wang Wenjing, Song Keqi, Ye Taiyang, Zhu Jie, Di Wen
Format: Article
Language:English
Published: De Gruyter 2022-01-01
Series:Open Medicine
Subjects:
Online Access:https://doi.org/10.1515/med-2022-0422
_version_ 1828381297093902336
author Dai Lan
Wang Chen
Wang Wenjing
Song Keqi
Ye Taiyang
Zhu Jie
Di Wen
author_facet Dai Lan
Wang Chen
Wang Wenjing
Song Keqi
Ye Taiyang
Zhu Jie
Di Wen
author_sort Dai Lan
collection DOAJ
description Epithelial ovarian cancer (EOC) is the leading cause of deaths due to cancer in women. Adipocytes have been suggested to play a key role in the stimulation of EOC growth. However, the mechanisms underlying the adipocyte-induced EOC proliferation remain undefined. Here, we provide the first evidence that adipocytes induce the activation of sphingosine kinase (SphK) 2 in EOC, which represents a novel pathway that mediates the adipocyte-induced EOC growth. SphK2 inhibition in EOC cells led to a remarkable inhibition of the adipocyte-induced cell proliferation. Moreover, the adipocyte-induced SphK2 activation in EOC cells was extracellular signal-regulated protein kinases (ERK) dependent. Furthermore, silencing SphK2 in EOC significantly inhibited the adipocyte-induced expression of phospho-ERK and c-Myc, two crucial players in EOC growth. Collectively, the current study unraveled a previously unrecognized role of SphK2 in the adipocyte-induced growth-promoting action in EOC, suggesting a novel target for EOC treatment.
first_indexed 2024-12-10T04:12:24Z
format Article
id doaj.art-7bbb10b80b06482a9e7c1fafa4de8848
institution Directory Open Access Journal
issn 2391-5463
language English
last_indexed 2024-12-10T04:12:24Z
publishDate 2022-01-01
publisher De Gruyter
record_format Article
series Open Medicine
spelling doaj.art-7bbb10b80b06482a9e7c1fafa4de88482022-12-22T02:02:41ZengDe GruyterOpen Medicine2391-54632022-01-0117122923810.1515/med-2022-0422Activation of SphK2 contributes to adipocyte-induced EOC cell proliferationDai Lan0Wang Chen1Wang Wenjing2Song Keqi3Ye Taiyang4Zhu Jie5Di Wen6Department of Obstetrics and Gynecology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, ChinaDepartment of Obstetrics and Gynecology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, ChinaDepartment of Obstetrics and Gynecology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, ChinaDepartment of Obstetrics and Gynecology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, ChinaDepartment of Obstetrics and Gynecology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, ChinaDepartment of Obstetrics and Gynecology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, ChinaDepartment of Obstetrics and Gynecology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, ChinaEpithelial ovarian cancer (EOC) is the leading cause of deaths due to cancer in women. Adipocytes have been suggested to play a key role in the stimulation of EOC growth. However, the mechanisms underlying the adipocyte-induced EOC proliferation remain undefined. Here, we provide the first evidence that adipocytes induce the activation of sphingosine kinase (SphK) 2 in EOC, which represents a novel pathway that mediates the adipocyte-induced EOC growth. SphK2 inhibition in EOC cells led to a remarkable inhibition of the adipocyte-induced cell proliferation. Moreover, the adipocyte-induced SphK2 activation in EOC cells was extracellular signal-regulated protein kinases (ERK) dependent. Furthermore, silencing SphK2 in EOC significantly inhibited the adipocyte-induced expression of phospho-ERK and c-Myc, two crucial players in EOC growth. Collectively, the current study unraveled a previously unrecognized role of SphK2 in the adipocyte-induced growth-promoting action in EOC, suggesting a novel target for EOC treatment.https://doi.org/10.1515/med-2022-0422epithelial ovarian canceradipocytessphingosine kinase 2proliferation
spellingShingle Dai Lan
Wang Chen
Wang Wenjing
Song Keqi
Ye Taiyang
Zhu Jie
Di Wen
Activation of SphK2 contributes to adipocyte-induced EOC cell proliferation
Open Medicine
epithelial ovarian cancer
adipocytes
sphingosine kinase 2
proliferation
title Activation of SphK2 contributes to adipocyte-induced EOC cell proliferation
title_full Activation of SphK2 contributes to adipocyte-induced EOC cell proliferation
title_fullStr Activation of SphK2 contributes to adipocyte-induced EOC cell proliferation
title_full_unstemmed Activation of SphK2 contributes to adipocyte-induced EOC cell proliferation
title_short Activation of SphK2 contributes to adipocyte-induced EOC cell proliferation
title_sort activation of sphk2 contributes to adipocyte induced eoc cell proliferation
topic epithelial ovarian cancer
adipocytes
sphingosine kinase 2
proliferation
url https://doi.org/10.1515/med-2022-0422
work_keys_str_mv AT dailan activationofsphk2contributestoadipocyteinducedeoccellproliferation
AT wangchen activationofsphk2contributestoadipocyteinducedeoccellproliferation
AT wangwenjing activationofsphk2contributestoadipocyteinducedeoccellproliferation
AT songkeqi activationofsphk2contributestoadipocyteinducedeoccellproliferation
AT yetaiyang activationofsphk2contributestoadipocyteinducedeoccellproliferation
AT zhujie activationofsphk2contributestoadipocyteinducedeoccellproliferation
AT diwen activationofsphk2contributestoadipocyteinducedeoccellproliferation